|
Pharma
stocks get a drubbing
On
the first trading day (Monday 22), stock prices recorded a significant
fall mainly due to jittery world markets and suspension of clinical
trials of a drug under development of Dr Reddy’s Laboratories.
The stock of DRL declined by 14 per cent during the day. The Bombay
Stock Exchange on Monday closed at 3153.34. On Friday 26, too, stock
prices across all segments registered a notable fall. The sensex
closed at 3024.35
The
major winners were: Aventis Pharma 389.45 (389); Cipla 936.75 (932.70);
Nicholas Piramal 255.40 (254.50); Procter & Gamble 449 (448.75);
Ranbaxy 913.15 (903.40).
The
losers were: Aurobindo Pharma 213.65 (218.70); Burroughs Wellcome
205 (205.80); Cadila Healthcare 132.65 (135.80); Dabur 47.90 (48.45);
Dr Reddy’s 831.95 (874.20); German Remedies 290 (292.50); Glaxo
379.60 (391.20); Merck 286.25 (295); Novartis 248.65 (249.75); Parke
Davis 195.50 (199.55); Pfizer 456.65 (464.70); Sun Pharma 549.60
(552.90); Wockhardt 477.30 (478.10);
|
